CASI Pharmaceuticals Cash Flow Statement (2020-2025) | CASIF

Cash Flow Statement Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -6.96M-6.39M-5.62M-15.03M-7.21M-9.43M-4.59M16.12M-9.65M-9.17M-9.05M-13.79M-10.58M-11.57M-10.04M-77.19M
Gains from Investment Securities (Quarter) 1.67M3.32M-1.55M-1.15M0.70M-0.05M-0.14M-0.94M0.01M2.88M1.86M1.25M-1.57M0.11M-0.02M1.80M
Non-cash Items (Quarter) 2.22M1.37M2.10M
Change in Working Capital
Change in Account Payables (Quarter) 3.29M2,374.00M4,438.00M0.58M792.00M1.76M2.72M1,195.00M0.81M0.56M
Change in Taxes (Quarter) 1.90M
Other Working Capital Changes (Quarter) 0.01M0.04M0.07M0.21M0.02M
Investing Activities
Divestments (Quarter) 2.50M
Financing Activities
Other financing activities (Quarter) -2019.00M
Additional items
Exchange Rate Effect (Quarter) 0.25M-3.54M-3.13M1.91M0.20M-2.18M-0.17M2.67M0.10M-0.32M-0.05M-0.80M-0.45M-0.01M-0.03M0.22M